查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873164

全球生物外科市场

Biosurgery
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球生物外科市场预计2030年将达到184亿美元。

全球生物外科市场规模在2024年估计为145亿美元，预计到2030年将达到184亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.1%。本报告分析的细分市场之一—骨移植替代材料，预计将以3.9%的复合年增长率成长，并在分析期结束时达到72亿美元。止血剂细分市场预计在分析期间将以3.6%的复合年增长率成长。

美国市场规模估计为39亿美元，而中国市场预计将以3.9%的复合年增长率成长。

据估计，2024年美国生物医学外科市场规模将达39亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到29亿美元，在2024年至2030年的分析期间内，年复合成长率（CAGR）为3.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的年复合成长率将分别达到3.7%和3.4%。在欧洲，德国的年复合成长率预计将达到约3.1%。

全球生物医学外科手术市场—主要趋势与驱动因素概述

什么是果冻？为什么它在现代医学中越来越受到重视？

果冻是医疗科技领域一个创新且快速发展的分支，但它究竟包含哪些内容呢？广义而言，果冻是指利用生物来源或生物相容性材料辅助外科手术。这些材料旨在与人体无缝结合，促进癒合，最大限度地减少併发症，并经常为传统外科技术提供替代方案。生物外科的应用范围十分广泛，涵盖止血（阻止出血的过程）、组织再生，甚至包括使用可与活体组织整合的生物活性植入。人们对微创手术日益增长的兴趣，以及对更快康復时间和更短住院时间的需求，显着提升了对生物外科技术的兴趣。随着全球医疗保健系统越来越重视患者疗效和成本效益，生物外科已稳固确立其作为现代外科护理基础技术的地位。

最尖端科技如何形塑生物外科的未来？

生物外科领域正因技术进步而发生翻天覆地的变化，但具体有哪些变化正在发生？其中一个最重要的进展是再生医学领域，它利用支架和生长因子等生物外科产品来促进受损组织的修復和替换。此外，奈米技术的应用使得更精密的生物材料的研发成为可能，这些材料能够将药物和其他治疗剂直接输送到手术部位，从而促进人体自身的癒合过程。机器人技术和影像技术也发挥关键作用，为外科医生在手术过程中提供了前所未有的精准度和控制力。此外，3D列印技术的出现使得客製化植入物和移植物成为可能，植入和移植物可根据患者的个别情况量身定制，从而降低排异反应的风险并改善治疗效果。随着这些技术的不断发展，生物外科的潜在应用范围将不断扩大，并有望彻底改变外科手术的进行方式。

为什么果冻正成为复杂外科手术的首选？

生物外科产品的独特功能正推动其在复杂且具挑战性的外科手术中广泛应用，但究竟是什么使其如此重要？在许多情况下，传统外科技术创伤过大或无法达到预期效果，尤其是涉及大面积组织损伤或精细结构的病例。生物外科产品，例如纤维蛋白胶、胶原蛋白基质和合成移植物，为外科医生提供了增强人体自然癒合过程、降低併发症风险并提高整体手术成功率的工具。例如，在心血管外科手术中，生物外科在血管修復和预防过度出血方面发挥着至关重要的作用。在整形外科手术中，生物活性材料正被用于促进骨再生和提高植入的完整性。此外，生物外科在创伤护理领域的应用也不断扩展，尤其是对传统治疗方法无效的慢性伤口。随着医疗产业不断面临人口老化和慢性病日益增多的挑战，生物外科在应对这些疾病方面的作用预计将变得更加重要。

推动生物外科市场快速扩张的因素有哪些？

果冻市场的成长受多种因素驱动，这些因素共同推动了对这些先进外科解决方案的需求不断增长。技术创新，特别是生物材料和再生医学领域的创新，显着拓展了果冻的应用范围，使其成为各个医学领域更具可行性的选择。此外，糖尿病和心血管疾病等慢性病的日益普遍，导致传统方法难以应对的复杂手术病例不断增加。消费者行为也在影响这一趋势，患者越来越倾向于选择微创手术，以缩短恢復时间并减少副作用。医疗服务提供者对生物外科的认知和接受度不断提高，也进一步推动了其应用，因为越来越多的临床医生认识到这些技术在改善患者预后方面的益处。此外，全球人口老化也促进了对生物外科产品的需求，因为老年患者更有可能需要受益于这些先进技术的外科手术。最后，政府的支持性政策和对医疗保健基础设施（尤其是在新兴市场）不断增加的投资，为生物外科市场的发展创造了有利环境，确保了这个充满活力的领域的持续增长和创新。

部分：

依产品（骨移植替代品、止血剂、软组织固定剂、外科密封剂、沾黏抑制剂）、依应用（一般外科、整形外科、整形外科、妇科手术、其他应用）、依最终用途（医院、诊所、其他最终用途）分类

受访公司范例

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding BV & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi US
  • Stryker Corporation

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在我们的最新报告中，全球产业分析师将关税对地域市场的影响纳入考量，并根据公司总部所在国、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP10738

Global Biosurgery Market to Reach US$18.4 Billion by 2030

The global market for Biosurgery estimated at US$14.5 Billion in the year 2024, is expected to reach US$18.4 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Hemostatic Agents segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 3.9% CAGR

The Biosurgery market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Biosurgery Market - Key Trends and Drivers Summarized

What Is Biosurgery, and Why Is It Gaining Traction in Modern Medicine?

Biosurgery is an innovative and rapidly evolving field within medical technology, but what exactly does it encompass? Broadly speaking, biosurgery involves the use of biologically-based or biocompatible materials to aid in surgical procedures. These materials are engineered to interact seamlessly with the human body, promoting healing, minimizing complications, and often providing alternatives to traditional surgical methods. The scope of biosurgery is extensive, covering areas such as hemostasis (the process of stopping bleeding), tissue regeneration, and even the use of bioactive implants that can integrate with living tissues. The growing emphasis on less invasive procedures, combined with the desire for faster recovery times and reduced hospital stays, has significantly increased interest in biosurgical techniques. As healthcare systems across the globe prioritize patient outcomes and cost-effectiveness, biosurgery is poised to become a cornerstone of modern surgical practice.

How Are Cutting-Edge Technologies Shaping the Future of Biosurgery?

The landscape of biosurgery is being dramatically transformed by advancements in technology, but how exactly are these changes unfolding? One of the most significant developments has been in the field of regenerative medicine, where biosurgical products such as scaffolds and growth factors are used to facilitate the repair or replacement of damaged tissues. Additionally, the integration of nanotechnology is allowing for the creation of more sophisticated biomaterials that can deliver drugs or other therapeutic agents directly to the site of surgery, enhancing the body's natural healing processes. Robotics and imaging technologies are also playing a crucial role, providing surgeons with unprecedented precision and control during procedures. Furthermore, the advent of 3D printing is opening up new possibilities for custom implants and grafts that are tailored to individual patients, reducing the risk of rejection and improving outcomes. As these technologies continue to evolve, the potential applications of biosurgery are expanding, promising to revolutionize the way surgeries are performed.

Why Is Biosurgery Becoming the Go-To Option for Complex Surgical Cases?

The unique capabilities of biosurgical products are driving their adoption in complex and challenging surgical cases, but what makes them so indispensable? In many instances, traditional surgical methods are either too invasive or unable to achieve the desired outcomes, particularly in cases involving extensive tissue damage or delicate structures. Biosurgical products, such as fibrin sealants, collagen-based matrices, and synthetic grafts, provide surgeons with tools that can enhance the body's natural ability to heal, reduce the risk of complications, and improve the overall success rate of surgeries. For example, in cardiovascular surgery, biosurgery is playing a pivotal role in the repair of blood vessels and the prevention of excessive bleeding. In orthopedic surgery, bioactive materials are being used to promote bone regeneration and improve the integration of implants. Moreover, biosurgery is finding increasing applications in wound care, particularly in chronic wounds that are resistant to conventional treatments. As the healthcare industry continues to grapple with the challenges of an aging population and the rising prevalence of chronic diseases, the role of biosurgery in managing these conditions is set to grow.

What Is Fueling the Rapid Expansion of the Biosurgery Market?

The growth in the biosurgery market is driven by several factors, each contributing to the increasing demand for these advanced surgical solutions. Technological innovations, particularly in biomaterials and regenerative medicine, have significantly expanded the range of applications for biosurgery, making it a more viable option across various medical disciplines. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is leading to an increase in complex surgical cases where traditional methods may fall short. Consumer behavior is also playing a role, with patients increasingly seeking out minimally invasive procedures that offer quicker recovery times and fewer side effects. The growing awareness and acceptance of biosurgery among healthcare providers further drive its adoption, as more clinicians recognize the benefits of these techniques in improving patient outcomes. Moreover, the aging global population is contributing to the demand for biosurgical products, as older patients are more likely to require surgical interventions that benefit from these advanced technologies. Finally, supportive government policies and increased investment in healthcare infrastructure, particularly in emerging markets, are providing the necessary environment for the biosurgery market to thrive, ensuring continued growth and innovation in this exciting field.

SCOPE OF STUDY:

The report analyzes the Biosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents, Anti-Adhesion Agents); Application (General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Biosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Minimally Invasive Surgeries Spurs Growth in Biosurgery Market
    • Advancements in Biomaterials and Tissue Engineering Expand Addressable Market Opportunity
    • Increased Use of Biosurgery in Cardiovascular and Orthopedic Procedures Drives Market Adoption
    • Here's How Technological Innovations in Hemostasis and Sealants Propel Market Growth
    • Growing Geriatric Population and Associated Chronic Conditions Generate Demand for Biosurgical Products
    • Emerging Applications of Biosurgery in Regenerative Medicine Sustain Long-Term Market Expansion
    • Shifts Towards Personalized Medicine and Customized Surgical Solutions Throw the Spotlight on Biosurgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION